Brain Stimulation + Cognitive Training for Mild Traumatic Brain Injury
(COGNETRIC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new home-based method to improve attention in individuals with a history of mild traumatic brain injury (mTBI), focusing specifically on active-duty service members and veterans. The study employs a brain stimulation technique called RS-tDCS+ (Remotely Supervised Transcranial Direct Current Stimulation combined with Cognitive Training) to enhance learning and reorganize brain connections. Participants will receive either the real treatment or a sham (placebo) version to determine any differences in attention improvement. The trial seeks individuals who experienced mTBI at least three months ago and face attention or concentration difficulties in daily life. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that may enhance cognitive recovery methods.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have been newly prescribed a medication within the last 3 weeks, you may not be eligible to participate.
What prior data suggests that this brain stimulation technique is safe for cognitive rehabilitation?
Research has shown that transcranial direct current stimulation (tDCS), including the remotely supervised version (RS-tDCS), is generally safe. Participants in studies have tolerated RS-tDCS well, with few negative effects reported. Specifically, a review of several trials found that side effects were rare and minor, with most people experiencing only mild sensations like tingling on the scalp.
One study used RS-tDCS at home and found it both safe and effective, particularly for improving symptoms in various conditions. This suggests that the treatment is suitable for use outside a medical setting, offering convenience without compromising safety.
Overall, while no treatment is completely risk-free, RS-tDCS has demonstrated a good safety record in various studies, making it a promising option for cognitive rehabilitation in mild traumatic brain injury.12345Why are researchers excited about this trial?
Researchers are excited about this treatment because it combines cognitive training with transcranial direct current stimulation (tDCS), a unique approach for addressing mild traumatic brain injury (mTBI). Unlike traditional options, which often rely on medications or cognitive therapies alone, this method uses a non-invasive technique to stimulate specific brain areas, potentially enhancing recovery. The remotely supervised tDCS+ allows patients to receive treatment at home, making it more accessible and convenient. This novel combination could lead to faster and more effective improvements in cognitive function, a significant advantage over existing therapies.
What evidence suggests that RS-tDCS+ is effective for improving complex attention in mTBI?
Research shows that Remotely Supervised Transcranial Direct Current Stimulation with Cognitive Training (RS-tDCS+) may improve attention in people with mild traumatic brain injury (mTBI). In this trial, participants will join either an active tDCS group or a sham tDCS group. Studies have found that tDCS can boost learning and help the brain form new connections, potentially enhancing thinking skills. While evidence is still growing, some research suggests it could also benefit similar conditions, such as multiple sclerosis. Early results are promising, but more research is needed to confirm its effectiveness specifically for mTBI.14678
Who Is on the Research Team?
Lars D Hungerford, PhD
Principal Investigator
United States Naval Medical Center, San Diego
Are You a Good Fit for This Trial?
This trial is for Active Duty Service Members and Veterans who have experienced mild Traumatic Brain Injury (mTBI) and are struggling with complex attention issues. Participants should be interested in a home-based cognitive rehabilitation program using brain stimulation and cognitive training.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 10 sessions of cognitive training combined with transcranial direct current stimulation (RS-tDCS) over 2 weeks, conducted remotely at home.
Post-Treatment Assessment
Participants undergo post-intervention assessments including EEG and MRI to evaluate changes in brain connectivity and function.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 1 and 6 weeks post-treatment.
What Are the Treatments Tested in This Trial?
Interventions
- Remotely Supervised tDCS+
Find a Clinic Near You
Who Is Running the Clinical Trial?
United States Naval Medical Center, San Diego
Lead Sponsor
The Defense and Veterans Brain Injury Center
Collaborator
Minneapolis Veterans Affairs Medical Center
Collaborator
University of Minnesota
Collaborator
Center for Veterans Research and Education
Collaborator
General Dynamics Information Technology
Collaborator
United States Department of Defense
Collaborator